Ileostomy Clinical Trials

Clinical trials related to Ileostomy Procedure

Investigation of in Vivo Endogenous and/or Exogenous Production of Phenolic Metabolites in People With an Ileostomy Using an Oral (Poly)Phenol Challenge Test

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Plant foods contain natural compounds called (poly)phenols, which may help lower the risk of heart and metabolic diseases. However, people differ greatly in how they absorb and process these compounds, partly because most (poly)phenols are broken down by gut bacteria in the colon. This makes it difficult to know exactly which metabolites come from the diet, and which are produced by the body. Studying people with an ileostomy provides a unique opportunity to understand how much is absorbed in the small intestine and how these compounds are transformed. This will help us better understand individual responses to dietary (poly)phenols.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Currently living with an ileostomy

• \> 1-year post-operative

• Aged 18 - 75 years

• BMI 18 - 28 kg/m2

• Males and females (not currently pregnant / lactating)

• Non-smokers (including vaping)

• Not taking antibiotic therapy 3 months prior to the study

• No phytochemical supplement usage 2 weeks prior to study start.

• Free-living (i.e. not housebound)

• No participation in other biomedical studies 3 months prior.

Locations
Other Locations
United Kingdom
Ulster University, Human Intervention Studies Unit, Coleraine, Co. Londonderry, BT521SA
RECRUITING
Coleraine
Contact Information
Primary
Chris IR Gill, PhD
c.gill@ulster.ac.uk
+44 28 7012 3181
Backup
Ruth Price, PhD
rk.price@ulster.ac.uk
+442870123878
Time Frame
Start Date: 2026-08
Estimated Completion Date: 2028-05
Participants
Target number of participants: 20
Treatments
Experimental: (Poly)phenol rich capsules
(Poly)phenol rich capsules (\~3 g)
Related Therapeutic Areas
Sponsors
Leads: University of Ulster
Collaborators: University of Parma

This content was sourced from clinicaltrials.gov